Escitalopram Oxalate Working Standard (Secondary Reference Standard)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

219861-08-2Escitalopram Oxalate Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:VE0027388
CAS No.:219861-08-2
Mol. Formula:C22H23FN2O5
Mol. Weight:414.43 g/mol

Additional information on CAS 219861-08-2

Parent drug

Escitalopram / Escitalopram Oxalate

IUPAC Name

(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluoro-phenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrogen oxalate

Smiles

CN(C)CCC[C@@]1(C2=CC=C(F)C=C2)OCC3=C1C=CC(C#N)=C3.O=C(O)C(O)=O

InChI

InChI=1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1

Description

Escitalopram Oxalate Working Standard (Secondary Reference Standard), CAS: 219861-08-2, is a high-purity characterized material produced to defined specifications for identity and purity. Each batch is supplied with a certificate of analysis detailing assay, impurity profile, residual solvents and full chromatograms, with identity confirmation by validated HPLC, NMR and mass spectrometry. The material is packaged to protect integrity with specified storage conditions and established expiry and lot traceability; stability data are provided to document analytical consistency. It is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url